Hyo S Han

6PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 10, 2025
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer.

Keith L Knutson, Hala Abu-Fares, Patricia Keating

|Jul 25, 2025
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.

Robert Wesolowski, Hope S Rugo, Jennifer M Specht

|Mar 18, 2025
A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer.

Hatem Soliman, Amy Aldrich, Neveen Abdo

|Nov 21, 2024
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases.

Vaseem M Khatri, Mariella A Mestres-Villanueva, Sreenija Yarlagadda

|Nov 21, 2024
Cancer-Related Cognitive Impairment and the Potential of Dietary Interventions for the Prevention and Mitigation of Neurodegeneration.

Sylvia L Crowder, Lisa M Gudenkauf, Aasha I Hoogland

|Dec 10, 2021
Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study.

Antoinette R Tan, Gail S Wright, Anu R Thummala

Pageof 1

Frequent Collaborators

1 joint publications

Ricardo Costa

1 joint publications

John Kiluk

1 joint publications

Bethany Niell

1 joint publications

Robert Wesolowski